Skip to main content
. 2013 Jun 28;8(6):e66842. doi: 10.1371/journal.pone.0066842

Figure 3. The expression levels of circulating miRNA-29c and recurrence analysis of the 107 patients with colorectal cancer (CRC).

Figure 3

(A) The expression levels of circulating miRNA-29c are deregulated in the serum samples from 23 healthy subjects, 41 non-early and 20 early-relapse CRC patients. Serum miRNA-29c levels were not significantly different between healthy subjects group and non-early-relapse group (P = 0.256). The expression level is significantly increased in the serum samples of early-relapse patients comparing to the healthy subjects group (P<0.0001) and non-early-relapse group (P = 0.012). (B) The recurrence analysis in CRC patients was assessed by the Kaplan-Meier method and the patterns of early relapsed (blank line) and non-early relapsed (gray line) groups were shown.